Literature DB >> 12944488

Molecular mechanisms associated with the regulation of apoptosis by the two alternatively spliced products of c-Myb.

Atul Kumar1, Stacey J Baker, Clement M Lee, E Premkumar Reddy.   

Abstract

The c-myb proto-oncogene encodes two alternatively spliced mRNAs, which in turn code for proteins of 75 kDa and 89 kDa. It is at present unclear whether the two isoforms of c-Myb perform identical functions or whether they mediate different biological effects. To assess their role in apoptotic death of hematopoietic cells, we expressed the two isoforms of c-Myb in the murine myeloid cell lines 32Dcl3 and FDCP1. Our results show that while ectopic overexpression of p75 c-Myb results in the acceleration of cell death, similar overexpression of p89 c-Myb results in the protection of cells from apoptotic death. An analysis of gene expression changes with mouse cDNA expression arrays revealed that while p75 c-Myb blocked the expression of glutathione S-transferase micro mRNA, p89 c-Myb greatly enhanced the expression of this gene. These results were further confirmed by Northern blot analysis. Ectopic overexpression of the glutathione S-transferase micro gene in 32Dcl3 cells resulted in protection of cells from interleukin-3 withdrawal-induced cell death similar to that seen with the ectopic overexpression of p89 c-Myb. These results suggest that the two isoforms of c-Myb differentially regulate apoptotic death of myeloid cells through differential regulation of glutathione S-transferase micro gene expression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12944488      PMCID: PMC193713          DOI: 10.1128/MCB.23.18.6631-6645.2003

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  68 in total

1.  AATYK: a novel tyrosine kinase induced during growth arrest and apoptosis of myeloid cells.

Authors:  E Gaozza; S J Baker; R K Vora; E P Reddy
Journal:  Oncogene       Date:  1997-12-18       Impact factor: 9.867

2.  Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked.

Authors:  J Yang; X Liu; K Bhalla; C N Kim; A M Ibrado; J Cai; T I Peng; D P Jones; X Wang
Journal:  Science       Date:  1997-02-21       Impact factor: 47.728

3.  The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis.

Authors:  R M Kluck; E Bossy-Wetzel; D R Green; D D Newmeyer
Journal:  Science       Date:  1997-02-21       Impact factor: 47.728

4.  Selection of effective antisense oligodeoxynucleotides with a green fluorescent protein-based assay. Discovery of selective and potent inhibitors of glutathione S-transferase Mu expression.

Authors:  Peter A C 't Hoen; Bram-Sieben Rosema; Jan N M Commandeur; Nico P E Vermeulen; Muthiah Manoharan; Theo J C van Berkel; Eric A L Biessen; Martin K Bijsterbosch
Journal:  Eur J Biochem       Date:  2002-05

5.  Murine A-myb gene encodes a transcription factor, which cooperates with Ets-2 and exhibits distinctive biochemical and biological activities from c-myb.

Authors:  I H Oh; E P Reddy
Journal:  J Biol Chem       Date:  1997-08-22       Impact factor: 5.157

6.  v-Myb of E26 leukemia virus up-regulates bcl-2 and suppresses apoptosis in myeloid cells.

Authors:  J Frampton; T Ramqvist; T Graf
Journal:  Genes Dev       Date:  1996-11-01       Impact factor: 11.361

7.  A dominant interfering Myb mutant causes apoptosis in T cells.

Authors:  D Taylor; P Badiani; K Weston
Journal:  Genes Dev       Date:  1996-11-01       Impact factor: 11.361

8.  Negative autoregulation of c-Myb activity by homodimer formation through the leucine zipper.

Authors:  T Nomura; N Sakai; A Sarai; T Sudo; C Kanei-Ishii; R G Ramsay; D Favier; T J Gonda; S Ishii
Journal:  J Biol Chem       Date:  1993-10-15       Impact factor: 5.157

9.  Resistance to apoptosis in CTLL-2 cells constitutively expressing c-Myb is associated with induction of BCL-2 expression and Myb-dependent regulation of bcl-2 promoter activity.

Authors:  P Salomoni; D Perrotti; R Martinez; C Franceschi; B Calabretta
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

10.  c-Myc is essential but not sufficient for c-Myb-mediated block of granulocytic differentiation.

Authors:  Atul Kumar; Clement M Lee; E Premkumar Reddy
Journal:  J Biol Chem       Date:  2003-01-13       Impact factor: 5.157

View more
  11 in total

1.  MicroRNA (miRNA)-mediated interaction between leukemia/lymphoma-related factor (LRF) and alternative splicing factor/splicing factor 2 (ASF/SF2) affects mouse embryonic fibroblast senescence and apoptosis.

Authors:  Lorena Verduci; Marcella Simili; Milena Rizzo; Alberto Mercatanti; Monica Evangelista; Laura Mariani; Giuseppe Rainaldi; Letizia Pitto
Journal:  J Biol Chem       Date:  2010-10-04       Impact factor: 5.157

2.  A non-ATP-competitive inhibitor of BCR-ABL overrides imatinib resistance.

Authors:  Kiranmai Gumireddy; Stacey J Baker; Stephen C Cosenza; Premila John; Anthony D Kang; Kimberly A Robell; M V Ramana Reddy; E Premkumar Reddy
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-27       Impact factor: 11.205

3.  p89c-Myb is not required for fetal or adult hematopoiesis.

Authors:  Stacey J Baker; Atul Kumar; E Premkumar Reddy
Journal:  Genesis       Date:  2010-05       Impact factor: 2.487

4.  The gene encoding the splicing factor SF2/ASF is a proto-oncogene.

Authors:  Rotem Karni; Elisa de Stanchina; Scott W Lowe; Rahul Sinha; David Mu; Adrian R Krainer
Journal:  Nat Struct Mol Biol       Date:  2007-02-18       Impact factor: 15.369

5.  MYB suppresses differentiation and apoptosis of human breast cancer cells.

Authors:  Yvette Drabsch; Ramsay G Robert; Thomas J Gonda
Journal:  Breast Cancer Res       Date:  2010-07-26       Impact factor: 6.466

6.  Alternative RNA splicing produces multiple forms of c-Myb with unique transcriptional activities.

Authors:  John P O'Rourke; Scott A Ness
Journal:  Mol Cell Biol       Date:  2008-01-14       Impact factor: 4.272

Review 7.  Myb proteins: angels and demons in normal and transformed cells.

Authors:  Ye Zhou; Scott A Ness
Journal:  Front Biosci (Landmark Ed)       Date:  2011-01-01

8.  Single molecule analysis of c-myb alternative splicing reveals novel classifiers for precursor B-ALL.

Authors:  Ye E Zhou; John P O'Rourke; Jeremy S Edwards; Scott A Ness
Journal:  PLoS One       Date:  2011-08-11       Impact factor: 3.240

9.  Expression of p89(c-Mybex9b), an alternatively spliced form of c-Myb, is required for proliferation and survival of p210BCR/ABL-expressing cells.

Authors:  G Manzotti; S A Mariani; F Corradini; R Bussolari; V Cesi; J Vergalli; G Ferrari-Amorotti; V Fragliasso; A R Soliera; S Cattelani; G Raschellà; T L Holyoake; B Calabretta
Journal:  Blood Cancer J       Date:  2012-05-11       Impact factor: 11.037

10.  c-Myb immunoreactivity, protein and mRNA levels significantly increase in the aged hippocampus proper in gerbils.

Authors:  In Koo Hwang; Seung Myung Moon; Ki-Yeon Yoo; Hua Li; Heum Dai Kwon; Hyung Sik Hwang; Sun Kil Choi; Bong-Hee Lee; Jong Dai Kim; Moo Ho Won
Journal:  Neurochem Res       Date:  2007-03-31       Impact factor: 4.414

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.